Protecting Canada's livestock industry with a new vaccine bank Français
OTTAWA ON, /CNW/ - Canada is making significant progress towards the creation of a dedicated foot-and-mouth disease (FMD) vaccine bank, which will build on existing protections for the livestock industry and equip producers with another tool to control and eliminate the disease should an outbreak occur.
Following a competitive procurement process, Public Services and Procurement Canada, on behalf of the Canadian Food Inspection Agency, awarded contracts to Boehringer Ingelheim Animal Health and Biogénesis Bagó SA to supply multiple types of vaccine products and develop Canada's first FMD vaccine bank. This FMD vaccine bank complements Canada's current access to vaccines through the North American Foot and Mouth Disease Vaccine Bank, ensuring readily available vaccines for Canadian producers.
FMD is a highly contagious and severe disease that affects cattle, sheep, swine, and other cloven-hoofed animals. An FMD infection can cause painful blisters that make it hard for animals to eat, walk, and produce milk, leaving them weak and sick.
Preparedness efforts, including building a Canadian FMD vaccine bank, are key to protecting Canadian animals and agriculture. Having a ready supply of FMD emergency vaccines will strengthen our ability to respond effectively to an outbreak should one occur. It could also reduce the number of cases and the duration of the outbreaks.
Collaboration between Canada's federal, provincial and territorial governments along with stakeholders plays a key role in Canada's FMD prevention and preparedness plans. These efforts, combined with Canada's existing strict import requirements, on-farm biosecurity measures, and disease surveillance, continue to protect the health of Canadian animals and the economic prosperity of our producers and farming communities.
Quotes
"Today's announcement highlights our continued commitment to enhancing Canada's animal disease preparedness and prevention plans. Securing our own supply of FMD emergency vaccines will not only help reduce the spread during a potential outbreak but also help protect the livelihood of Canadian farmers by minimizing the impact on international trade."
-Paul MacKinnon, President, Canadian Food Inspection Agency
"Establishing a dedicated FMD vaccine bank is a vital tool in safeguarding the health of our livestock, market access and the future of our industry. CFIA's announcement marks a key milestone towards our shared goal of strengthening Canada's preparedness against the threat of foot-and-mouth disease. We will continue to work with governments and stakeholders to ensure Canada has a robust emergency preparedness and prevention strategy against FMD."
-Tyler Fulton, President, Canadian Cattle Association
"The FMD vaccine bank is an important investment in protecting Canadian livestock and livestock producers from this disease. The federal government's support is further proof the cooperative relationship between government and industry in Canada works for producers and processors from coast to coast. We look forward to continuing this partnership on other challenges together."
- René Roy, Chair, Canadian Pork Council
"Today's announcement is a welcome and pivotal step towards enhancing existing industry defenses, offering producers another critical tool to minimize the impact and return Canada back to 'FMD-free' status in the event of an outbreak. This is vital for protecting animal health and farm sustainability, contributing to a safe, reliable, and consistent food supply for Canadians."
-David Wiens, President, Dairy Farmers of Canada
Quick Facts
Budget 2023 committed $57.5 million over five years, with $5.6 million ongoing, to the CFIA to establish an FMD vaccine bank for Canada, and to further develop FMD response plans.
FMD is considered one of the greatest economic threats to Canadian animal agriculture and the economic impacts in Canada are estimated to between $22B and $75B (in 2025 CAD) depending on the mode of introduction and extent of spread.
Canada has been free from FMD since 1952, and strict measures are in place to prevent the disease from entering Canada. FMD is not a public health risk and is not considered a food safety issue.
Public Services and Procurement Canada led an open, fair and transparent competitive procurement process to establish the contract for the FMD vaccine bank. Information about the solicitation is available on CanadaBuys.
Each day, hard-working CFIA employees—including inspectors, veterinarians and scientists—inspect food for safety risks, protect plants from pests and invasive species, and respond to animal diseases that could threaten Canada's national herd and human health. Guided by science-based decision-making and modern regulations, the Agency works tirelessly to ensure access to safe and healthy food in Canada, and support access to international markets for our high-quality agricultural products. To learn more, visit inspection.canada.ca.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Vancouver Sun
an hour ago
- Vancouver Sun
Canadians still waiting longer for surgeries than before COVID
The massive surgical backlogs left after rolling pandemic lockdowns are clearing but Canadians are still waiting longer than they were pre-COVID for new hips and knees, cancer surgeries and other 'priority' procedures, new data show. Even though 26 per cent more hip and knee replacements were done in 2024 than 2019, it still wasn't enough to meet the need: just 68 per cent of Canadians received a hip replacement within the 26-week benchmark last year, compared to 75 per cent in 2019. For those needing a knee replacement, 61 per cent got a slot in the operating room within the 182-day threshold, compared with 70 per cent in 2019, even though 21 per cent more knee replacements were performed in 2024 than in 2019. Start your day with a roundup of B.C.-focused news and opinion. By signing up you consent to receive the above newsletter from Postmedia Network Inc. A welcome email is on its way. If you don't see it, please check your junk folder. The next issue of Sunrise will soon be in your inbox. Please try again Interested in more newsletters? Browse here. Median wait times for breast, bladder, colorectal, lung and prostate cancer surgery also rose, with prostate cancer seeing the biggest bump in wait times, an extra nine days over 2019. Wait times for scans to diagnose diseases and injuries also increased, 'with MRI scans requiring an additional 15 days and CTS scans three more days compared with 2019,' the Canadian Institute for Health Information (CIHI) reported in a background release. Canadians waited a median 57 days for an MRI scan in 2024. One in 10 waited 198 days. The longer people wait, the more they deteriorate. Delays getting to an operating room 'can lead to disease progression, increased symptoms of anxiety and depression, risk of mental health flareups and worsening of surgical and nonsurgical patient outcomes,' Canadian researchers have warned. Hospitals across the country pushed back non-urgent surgeries during the early waves of COVID to free up beds. Almost 600,000 fewer operations were performed in the first 22 months of the pandemic alone compared to 2019, CIHI reported. The backlog has meant that by the time people see a surgeon, their problem is more complex than it would have been in the past, Dr. James Howard, chief of orthopedic surgery at University Hospital – London Health Sciences Centre said in the news release. Canada's aging baby boomer generation, with arthritis and other joint conditions, is also putting pressure on the system. 'So even with surgeons collectively working as much as they can and completing more surgeries than we have in the past, we are not seeing wait times come down due to the complexity and volume of patients presenting to orthopedic surgeons,' Howard said. While case numbers are bouncing back — five per cent more surgeries of all types were performed in 2023 than in 2019 — the volumes still haven't kept up with population growth (seven per cent over the same period) or the 10 per cent rise in demand for surgery among those 65 and older, CIHI reported. 'Although an increase in the volume of procedures performed across Canada means that the surgical backlog from the height of the pandemic period has effectively been cleared, ripple effects in the health systems — due in part to the pandemic — persist that impact wait times in Canada,' CIHI's Cheryl Chui, director of health system analytics, said in a statement. Factors driving those longer wait times include a shortage of specialists and nurses, limited operating room time, space and staff, and emergency cases that take priority over scheduled ones. Ontario and other provinces are trying to push through more surgeries and procedures, partly by doing more on an outpatient basis, meaning no overnight hospital stay. Ontario has also announced plans to expand the number of private clinics providing publicly covered hip and knee replacements. Other provinces have done the same, though 'the impact on surgical volumes and wait times is still being assessed,' CIHI said. According to the agency's latest waitlist snapshot, while the number of hip replacements increased from 22,000 in 2019, to 28,000 in 2024, and the number of knee replacements from 35,000 to 42,000 over the same period, a smaller proportion of people received joint replacement surgery within the recommended six months. Nationally, in 2024, only 68 per cent of people needing a new hip were treated within the 26-week benchmark, compared to 75 per cent in 2019. Ontario fared better than all other provinces: 82 per cent of hip replacement patients were treated within that timeframe. Newfoundland and Labrador (41 per cent) and Prince Edward Island (45 per cent) performed the worst. British Columbia (63 per cent), Saskatchewan (50 per cent), Manitoba (54 per cent) and Quebec (49 per cent) also scored below the proportion nationally. In Alberta, 73 per cent of hip replacements were performed within the benchmark in 2024. Ripple effects in the health systems — due in part to the pandemic — persist that impact wait times in Canada Overall, patients waited a median 125 days for hip surgery in 2024 (half waited less, half waited more). One in 10 waited 340 days. For knee replacements, 79 per cent of patients in Ontario received surgery within the 26-week benchmark in 2024, compared to 38 per cent in Quebec, 47 per cent in Saskatchewan, 55 per cent in B.C. and 62 per cent in Alberta. While efforts are being made to better manage and monitor surgical waitlists, researchers have warned that people with severe pain or worsening symptoms aren't being prioritized. Wait times for cataract surgery were close to pre-pandemic levels — 69 per cent of people were treated within a 16-week benchmark in 2024 versus 70 per cent in 2019. The percentage of people who received radiation therapy within 28 days and surgery to repair a fractured hip within 48 hours dropped slightly, by three percentage points from 2019 to 2024, falling to 94 per cent and 83 per cent, respectively. The volume of prostate cancer surgeries performed dropped by three per cent, from 3,500 in 2019, to 3,400 in 2024. And men waited longer for the procedure — from a median 41 days in 2019, to 50 days in 2024. Slower-growing cancers like prostate cancer tend to have the longest surgical wait times, CIHI reported. Median wait times for breast cancer surgery increased from 18 days in 2019 to 23 days in 2024, and wait times for bladder cancer increased from 24 days to 28 days. National Post Our website is the place for the latest breaking news, exclusive scoops, longreads and provocative commentary. Please bookmark and sign up for our daily newsletter, Posted, here .
Vancouver Sun
6 hours ago
- Vancouver Sun
Opinion: Exercise improves cancer survival — and a Canadian study leads the way
Last week, history was made in the world of cancer research — not with a new drug, but with something far more accessible and powerful: exercise. A landmark study published in The New England Journal of Medicine has confirmed, for the first time in a randomized controlled trial, that a structured exercise program can significantly improve survival for people treated for early-stage colon cancer. The Challenge trial showed that a three-year structured exercise program initiated after chemotherapy reduced the risk of cancer recurrence or death by 28 per cent, and improved overall survival by 37 per cent. Compared to health education alone, this was a 7.1 per cent improvement in the likelihood of being alive at the eight-year mark. Let that sink in: Brisk walking a few times a week can improve survival as much — or more — than many modern cancer drugs, with none of the side effects and at a fraction of the cost. A daily roundup of Opinion pieces from the Sun and beyond. By signing up you consent to receive the above newsletter from Postmedia Network Inc. A welcome email is on its way. If you don't see it, please check your junk folder. The next issue of Informed Opinion will soon be in your inbox. Please try again Interested in more newsletters? Browse here. For years, observational studies hinted that physically active cancer survivors tended to live longer and feel better. But these studies were limited by their design — confounded by the fact that healthier people might be more likely to exercise. Now, the Challenge trial provides the gold-standard evidence we've been waiting for — led by Drs. Christopher Booth and Kerry Courneya through the Canadian Cancer Trials Group, this 'first-in-class' trial enrolled 889 patients in Canada, Australia, and the UK and confirmed that supervised exercise with behaviour change support improves both disease-free and overall survival, while enhancing physical functioning and quality of life. This has profound implications for cancer care — and for our health system. First, it's time to redefine 'treatment.' Cancer care has long focused on surgery, chemotherapy, and radiation. But what happens after treatment is often an afterthought. Survivors may be left with side effects, fatigue, and fear of recurrence, and limited resources to support them. The Challenge trial flips that paradigm: recovery isn't passive. Exercise is not a 'nice to have' — it is a powerful, life-prolonging intervention. Second, access to structured exercise programs are not currently a standard-of-care for cancer survivors in Canada. That must change. These programs require relatively modest investment compared to the high costs of systemic therapies — yet they deliver survival benefits on par with expensive drugs. And unlike drugs, exercise can also reduce cardiovascular risk, improve mental health, and enhance overall quality of life. Third, this is a Canadian success story. The Challenge trial was conceived, led, and executed by Canadian investigators. The Canadian Cancer Society, together with global partners, funded this 15-year effort — a testament to the power of sustained investment in publicly funded clinical research. At a time when Canada's health research ecosystem faces financial strain, the success of Challenge highlights what's possible when we back bold ideas with the resources they deserve. Finally, the findings call on all of us — policymakers, cancer agencies and clinicians — to act. We must embed exercise into survivorship care across the country and simply telling people to exercise is not enough. This will require funding to support exercise professionals in cancer centres and the community, build incentives for survivor-focused programming, and eliminate structural barriers to participation. Survivorship care is not optional — it's essential. Of course, exercise is not a cure-all. Some patients may be unable to participate due to comorbidities or limitations. But for the majority, supervised aerobic activity like walking or cycling can and should be part of the care plan. Importantly, the Challenge program was designed to be adaptable and accessible — guided by behavioural science, delivered by trained consultants, and tailored to each patient's fitness level. We should applaud the Challenge investigators, the Canadian Cancer Trials Group, and the hundreds of patients who participated in this transformative trial. Their commitment will change how we support people after cancer — not just in Canada, but around the world. Now, it's our turn to rise to the challenge. Dr. Sharlene Gill is a medical oncologist at B.C. Cancer, professor of medicine at the University of B.C., and chair of the GI Disease Site for the Canadian Cancer Trials Group.
Cision Canada
9 hours ago
- Cision Canada
New Book Addresses Mental Health Crisis Among Men with Honest, Practical Approach
"Mental Health for Men: Daily Reminders to Stop Being So Hard On Yourself" Offers Real Solutions for Modern Masculine Challenges VANCOUVER, BC, June 11, 2025 /CNW/ - Author James R.C. Smith releases his groundbreaking new book, " Mental Health for Men: Daily Reminders to Stop Being So Hard on Yourself," addressing the largely overlooked mental health crisis affecting millions of men worldwide. Available now on Amazon, this 86-page fillable journal and handbook offers a no-nonsense approach to male mental wellness that breaks through traditional barriers and outdated expectations. The Silent Struggle The statistics are sobering: nearly one in three men experience moderate to high anxiety, and one in five face depression, yet men remain the demographic least likely to seek help or discuss their mental health openly. Smith's book directly confronts this crisis, offering practical tools and honest insights for men exhausted by society's impossible standards. "We've been handed an outdated manual that tells us never to show weakness, figure it out ourselves, and just 'man up,'" says Smith. "But how's that working out for us? The strongest thing you can do as a man is ask for help. Just because you CAN do it alone doesn't mean you SHOULD." A Different Kind of Self-Help Unlike traditional self-help books that promise transformation into a "zen master," Smith's approach is refreshingly realistic. The book acknowledges the unique challenges modern men face—from remote work pressures to digital parenting demands, constant connectivity, and the impossible expectation to be both traditionally masculine and emotionally available. The handbook includes: Research-backed strategies that fit into busy lifestyles Cognitive behavioral therapy techniques presented in accessible language Permission-giving exercises for imperfection in work, parenting, and relationships Practical guidance on asking for help without feeling like a failure Honest reflection exercises from someone who's "been there" Breaking the Stigma "Your mental health isn't a luxury—it's essential," Smith emphasizes. "And taking care of it isn't soft—it's as crucial as changing your oil, eating your veggies, or getting enough sleep." The book's direct, unfiltered tone resonates with men who are tired of being told to suppress their struggles while simultaneously being expected to be emotionally available. Smith's approach combines vulnerability with practicality, offering tools that actually work for real men living real lives. About the Author brings personal experience and research-backed insights to the conversation about men's mental health. Writing from the perspective of someone who has faced the same challenges as his readers, Smith offers authentic guidance rather than distant expertise. Availability "Mental Health for Men: Daily Reminders to Stop Being So Hard on Yourself" is available now on Amazon in hardcover format. The book features 86 pages of practical content designed for busy men who need real solutions, not empty promises. Book Details: Title: Mental Health for Men: Daily Reminders to Stop Being So Hard On Yourself Author: James R.C. Smith Publisher: IngramSpark Publication Date: June 6, 2025 Format: Hardcover, 86 pages ISBN-13: 978-1069562708 Available: Amazon and other major retailers
